Novamax Lands $180 Million Flu Vaccine Contract From U.S. Dept. Of Health
The United States Department of Health and Human Services has offered a contract to Novamax, Inc. for development of vaccines for the flu virus.
The United States Department of Health and Human Services has offered a contract to Novamax, Inc. for development of vaccines for the flu virus.
While some may think it is too late to receive a vaccination, that is definitely not the case, according to health experts.
The United States is currently experiencing a greater number of flu cases than ever before, health official explain.
Many scientists have been searching for ways to decrease production time of formulating and mass-producing various vaccines.
Experts released a figure explaining the flu has accounted for nearly 10 percent of adult deaths, officially placing the flu season this year at what could be classified as an epidemic.
What researchers discovered was that the vaccine antigenetically matched influenza strains at a near 80 percent level of effectiveness.
Researchers explain that zinc could not only reduce the length of the cold, but also the severity of the coughing, sneezing, and sniffling.
Typically each year, flu season peaks during February and tapers off after the month as spring comes around.
A new strain of the flu virus, which affected humans, killed millions of people and made the World Health Organization declare the pandemic outbreak of the influenza B flu.
A new study may prove just how the flu virus (both swine flu and ‘regular’ flu) is passed from child to child or person to person.